These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 21392116)
1. Successful treatment of microstomia with UVA1 phototherapy in systemic sclerosis. Tewari A; Garibaldinos T; Lai-Cheong J; Groves R; Sarkany R; Branislav Novakovic L Photodermatol Photoimmunol Photomed; 2011 Apr; 27(2):113-4. PubMed ID: 21392116 [No Abstract] [Full Text] [Related]
2. Low-dose UVA1 phototherapy for proximal and acral scleroderma in systemic sclerosis. Rose RF; Turner D; Goodfield MJ; Goulden V Photodermatol Photoimmunol Photomed; 2009 Jun; 25(3):153-5. PubMed ID: 19438995 [TBL] [Abstract][Full Text] [Related]
3. Successful ultraviolet A1 phototherapy in the treatment of localized scleroderma: a retrospective and prospective study. Andres C; Kollmar A; Mempel M; Hein R; Ring J; Eberlein B Br J Dermatol; 2010 Feb; 162(2):445-7. PubMed ID: 19785603 [TBL] [Abstract][Full Text] [Related]
5. Ultraviolet A1 phototherapy decreases inhibitory SMAD7 gene expression in localized scleroderma. Kreuter A; Hyun J; Skrygan M; Sommer A; Tomi NS; Breuckmann F; Altmeyer P; Gambichler T Arch Dermatol Res; 2006 Nov; 298(6):265-72. PubMed ID: 17009056 [TBL] [Abstract][Full Text] [Related]
6. Altered decorin expression of systemic sclerosis by UVA1 (340-400 nm) phototherapy: immunohistochemical analysis of 3 cases. Sawada H; Isogai Z; Morita A BMC Dermatol; 2003 Mar; 3():2. PubMed ID: 12689342 [TBL] [Abstract][Full Text] [Related]
7. Ultraviolet A1 phototherapy for treatment of acrosclerosis in systemic sclerosis: controlled study with half-side comparison analysis. Durand F; Staumont D; Bonnevalle A; Hachulla E; Hatron PY; Thomas P Photodermatol Photoimmunol Photomed; 2007 Dec; 23(6):215-21. PubMed ID: 17986056 [TBL] [Abstract][Full Text] [Related]
8. Irradiation with water-filtered infrared A plus visible light improves cutaneous scleroderma lesions in a series of cases. von Felbert V; Kernland-Lang K; Hoffmann G; Wienert V; Simon D; Hunziker T Dermatology; 2011; 222(4):347-57. PubMed ID: 21757879 [TBL] [Abstract][Full Text] [Related]
9. Medium dose long-wavelength ultraviolet A (UVA1) phototherapy for the treatment of acute and chronic graft-versus-host disease of the skin. Wetzig T; Sticherling M; Simon JC; Hegenbart U; Niederwieser D; Al-Ali HK Bone Marrow Transplant; 2005 Mar; 35(5):515-9. PubMed ID: 15665847 [TBL] [Abstract][Full Text] [Related]
10. [Ultraviolet-A1 (UVA1) phototherapy in lichen sclerosus et atrophicus]. Kreuter A; von Kobyletzki G; Happe M; Herde M; Breuckmann F; Stücker M; Altmeyer P Hautarzt; 2001 Oct; 52(10):878-81. PubMed ID: 17690817 [TBL] [Abstract][Full Text] [Related]
11. UVA1 phototherapy is effective in darker skin: a review of 101 patients of Fitzpatrick skin types I-V. Jacobe HT; Cayce R; Nguyen J Br J Dermatol; 2008 Sep; 159(3):691-6. PubMed ID: 18544076 [TBL] [Abstract][Full Text] [Related]
12. Ultrastructural changes induced in cutaneous collagen by ultraviolet-A1 and psoralen plus ultraviolet A therapy in systemic sclerosis. Sakakibara N; Sugano S; Morita A J Dermatol; 2008 Feb; 35(2):63-9. PubMed ID: 18271800 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of UVA1 phototherapy in 230 patients with various skin diseases. Rombold S; Lobisch K; Katzer K; Grazziotin TC; Ring J; Eberlein B Photodermatol Photoimmunol Photomed; 2008 Feb; 24(1):19-23. PubMed ID: 18201353 [TBL] [Abstract][Full Text] [Related]
14. A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma. Kreuter A; Hyun J; Stücker M; Sommer A; Altmeyer P; Gambichler T J Am Acad Dermatol; 2006 Mar; 54(3):440-7. PubMed ID: 16488295 [TBL] [Abstract][Full Text] [Related]
15. Ultraviolet-A1 phototherapy modulates Th1/Th2 and Tc1/Tc2 balance in patients with systemic lupus erythematosus. Szegedi A; Simics E; Aleksza M; Horkay I; Gaál K; Sipka S; Hunyadi J; Kiss E Rheumatology (Oxford); 2005 Jul; 44(7):925-31. PubMed ID: 15827034 [TBL] [Abstract][Full Text] [Related]
16. UVA1 irradiation attenuates collagen production via Ficz/AhR/MAPK signaling activation in scleroderma. Shi Y; Xiao Y; Yu J; Liu J; Liu L; Ding Y; Qiu X; Zhan Y; Tang R; Zeng Z; Xiao R Int Immunopharmacol; 2023 Mar; 116():109764. PubMed ID: 36706594 [TBL] [Abstract][Full Text] [Related]
17. Long-term efficacy of medium-dose UVA1 phototherapy in atopic dermatitis. Abeck D; Schmidt T; Fesq H; Strom K; Mempel M; Brockow K; Ring J J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):254-7. PubMed ID: 10642681 [TBL] [Abstract][Full Text] [Related]
18. Low-dose UVA1 phototherapy in systemic sclerosis: effects on acrosclerosis. Kreuter A; Breuckmann F; Uhle A; Brockmeyer N; Von Kobyletzki G; Freitag M; Stuecker M; Hoffmann K; Gambichler T; Altmeyer P J Am Acad Dermatol; 2004 May; 50(5):740-7. PubMed ID: 15097958 [TBL] [Abstract][Full Text] [Related]
20. [Microstomia as a complication of scleroderma]. Phoa KH; de Baat P; de Baat C Ned Tijdschr Tandheelkd; 2003 Nov; 110(11):457-9. PubMed ID: 14669488 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]